Is Cambrex Corporation (CBM) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Cambrex Corp (CBM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sand Grove Capital Partners Simon Davies | 0 | $0 | 0% | |
| 2. | Alyeska Investment Group Anand Parekh | 0 | $0 | 0% | |
| 3. | Paloma Partners Donald Sussman | 0 | $0 | 0% | |
| 4. | Quantamental Technologies Ran Pang | 0 | $0 | 0% | |
| 5. | AQR Capital Management Cliff Asness | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.10 | 750 | Director | 928 | 2016-03-15 | Filing | |
| $22.28 | 600 | Director | 1,350 | 2014-08-05 | Filing | |
| $4.25 | 4,000 | Director | 135,090 | 2011-08-23 | Filing | |
| $4.54 | 9,900 | Director | 131,090 | 2011-08-17 | Filing | |
| $4.25 | 100 | Director | 121,190 | 2011-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.00 | 193,903 | Officer | 0 | 2019-12-04 | Filing | |
| $60.00 | 35,796 | Director | 0 | 2019-12-04 | Filing | |
| $60.00 | 165,925 | Officer | 0 | 2019-12-04 | Filing | |
| $60.00 | 347,206 | Officer, Director | 0 | 2019-12-04 | Filing | |
| $60.00 | 62,668 | Director | 0 | 2019-12-04 | Filing |
Institutional Investors' Holdings
News See All
Here's What Hedge Funds Think About Cambrex Corporation (CBM)
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...
Hedge Funds Are Crazy About Cambrex Corporation (CBM)
Is Cambrex Corporation (NYSE:CBM) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Cambrex Corporation (CBM): 33% Downside Risk According to Lakewood Capital Investor Letter
Analysts remain optimistic that Cambrex Corporation (NYSE:CBM) will enjoy revenue and earnings growth next year despite sales pressure on its leading product; Anthony Bozza of Lakewood Capital believes...
Hedge Funds Are Buying Cambrex Corporation (CBM)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Why These 5 Stocks Are Enjoying Healthy Gains Today
With Wall Street trading with mixed results amid world growth concerns on Tuesday, shares of Cerus Corporation (NASDAQ:CERS), Owens & Minor, Inc.
Insiders Are Unloading Shares at These 3 Companies
It is commonly known that corporate insiders sell their companies’ stock for a wide array of reasons, most of which are not related to their companies’ current developments or future performance.
Hedge Funds Are Crazy About Cambrex Corporation (CBM)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
Dyax Corp. (DYAX): Are Hedge Funds Right About This Stock?
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Warner Chilcott Plc (WCRX) & Actavis Inc (ACT): Can You Profit From This Pharma Tie-Up
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.